You may not realize you’ve benefited from HIV research. But if you’ve received a treatment that was approved through a recent ...

Fred Hutch bioengineer Dr. Matthias Stephan is working to develop a special foam that could help make gene therapy for blood ...

GVHD can range from mild and temporary to life-threatening and chronic — but the deadly, debilitating cases are rare now. As ...

Fred Hutch's Value in Cancer Care conference, held November 6, focused on patient and provider burnout; the growing data ...

In this episode of the Oncology Insights Podcast, Dr. Petros Grivas welcomes Dr. Christina Rodriguez to discuss her journey ...

Our research on cell-based therapies also includes cutting-edge immunotherapies that harness the patient’s own immune cells to fight disease, including genetic engineering of immune cells to attack ...

HICOR’s Value in Cancer Care Initiative (VCCI) engages oncology providers, patient partners, payers, health system representatives and researchers to improve the value of cancer care delivery in ...

A new $5.2 million grant from the Washington Research Foundation will help develop a new clinical trials program between Fred Hutch Cancer Center and Seattle Children’s Research Institute.

Bisphosphonates are popular bone-targeting drugs. Older people take them to prevent and treat osteoporosis. Breast cancer patients, particularly those with metastatic disease, take them to prevent and ...

If there is one thing most of us have learned about the coronavirus itself, we know it is covered with spikes. In news broadcasts about the COVID-19 crisis, that gray Styrofoam ball dotted with red ...

Tucked away in the Pacific Northwest, Fred Hutch Cancer Center blazed an unusual path when it opened its doors 50 years ago — one of the first eight new comprehensive centers authorized by the 1971 ...

Early in 2020, Dr. Paul M. Buckley stepped into the newly created role of administrative director of Fred Hutchinson Cancer Research Center’s new Office of Diversity, Equity and Inclusion. With ...